The promise of signal transduction in genetically driven sarcomas of the nerve.
Document Type
Journal Article
Publication Date
1-1-2018
Journal
Experimental neurology
Volume
299
Issue
Pt B
Inclusive Pages
317-325
DOI
10.1016/j.expneurol.2017.08.014
Keywords
Animals; Antineoplastic Agents; Clinical Trials as Topic; Genes, Neurofibromatosis 1; Genes, Tumor Suppressor; Genes, ras; Humans; Loss of Function Mutation; MAP Kinase Signaling System; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Neurilemmoma; Neurofibromatosis 1; Neurofibromin 1; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Sarcoma; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays
APA Citation
Kim, A., & Pratilas, C. (2018). The promise of signal transduction in genetically driven sarcomas of the nerve.. Experimental neurology, 299 (Pt B). http://dx.doi.org/10.1016/j.expneurol.2017.08.014
Peer Reviewed
1
